BWX Technologies (BWX Technologies) Total Liabilities : $1,814 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is BWX Technologies Total Liabilities?

BWX Technologies's Total Liabilities for the quarter that ended in Dec. 2023 was $1,814 Mil.

BWX Technologies's quarterly Total Liabilities increased from Jun. 2023 ($1,899.05 Mil) to Sep. 2023 ($1,904.93 Mil) but then declined from Sep. 2023 ($1,904.93 Mil) to Dec. 2023 ($1,813.76 Mil).

BWX Technologies's annual Total Liabilities increased from Dec. 2021 ($1,864.15 Mil) to Dec. 2022 ($1,870.58 Mil) but then declined from Dec. 2022 ($1,870.58 Mil) to Dec. 2023 ($1,813.76 Mil).

BWX Technologies Total Liabilities Historical Data

The historical data trend for BWX Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BWX Technologies Total Liabilities Chart

BWX Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,504.80

1,675.74

1,864.15

1,870.58

1,813.76

BWX Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															1,870.58	1,930.90	1,899.05	1,904.93	1,813.76

BWX Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BWX Technologies's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	375.046	+	(1203.422	+	134.044
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	101.252)
	=	1,814

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2747.065	-	933.301
	=	1,814

BWX Technologies's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	375.046	+	(1203.422	+	134.044
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	101.252)
	=	1,814

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	2747.065	-	933.301
	=	1,814

BWX Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of BWX Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BWX Technologies (BWX Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Aerospace & Defense » BWX Technologies Inc (NYSE:BWXT) » Definitions » Total Liabilities

Comparable Companies

WWD CW HXL DRS HII MOG.A AVAV SPR KTOS MRCY RTX LMT BA XPAR:AIR NOC GD XPAR:SAF TDG LSE:BA. LHX

Traded in Other Exchanges

4BW:Germany 4BW:Germany

Address

800 Main Street, 4th Floor, Lynchburg, VA, USA, 24504

Website

https://www.bwxt.com

BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.

Executives

Michael Thomas Fitzgerald	officer: VP & Chief Accounting Officer	11525 N. COMMUNITY HOUSE ROAD, SUITE 600, CHARLOTTE NC 28277
Robert L Duffy	officer: SVP and Chief Admin. Officer	HARRIS CORPORATION, 1025 W. NASA BOULEVARD, MELBOURNE FL 32919
Robert L Nardelli	director	2455 PACES FERRY ROAD, ATLANTA GA 30339
Gerhard F Burbach	director	C/O THORATEC CORPORATION, 6035 STONERIDGE DRIVE, PLEASANTON CA 94588
Whitford Ronald Owen Jr	officer: SVP, General Counsel and Sec.	800 MAIN STREET, LYNCHBURG VA 24504
Omar Fathi Meguid	officer: SVP and Chief Digital Officer	800 MAIN STREET, LYNCHBURG VA 24504
Richard W Loving	officer: SVP, Human Resources	800 MAIN STREET, LYNCHBURG VA 24504
Jason S. Kerr	officer: See Remarks	11215 N. COMMUNITY HOUSE ROAD, CHARLOTTE NC 28277
John A Fees	director, officer: Executive Chairman	800 MAIN STREET, 4TH FLOOR, LYNCHBURG VA 24504
Thomas E Mccabe	officer: SVP & General Counsel	C/O ORBITAL SCIENCES CORPORATION, 45101 WARP DRIVE, DULLES VA 20166
Kevin M Mccoy	officer: Pres., Government Operations	800 MAIN STREET, LYNCHBURG NC 24504
Robb A. Lemasters	director	800 MAIN STREET, LYNCHBURG VA 24504
David S Black	officer: See Remarks	800 MAIN STREET, LYNCHBURG VA 24504
Rex D Geveden	officer: Chief Operating Officer	800 MAIN STREET, LYNCHBURG VA 24504
Robert Fendlay Smith	officer: President, Gov. Operations	800 MAIN STREET, LUNCHBURG VA 24504